CS Paper Radar

ProtoCouncil: Multi-Encoder Anatomical Prototypes for Prostate Cancer Detection in Micro-Ultrasound

Mohammad Mahdi Abootorabi, Nooshin Maghsoodi, Armin Saadat, Obed Dzikunu, Zhuoxin Guo, Hannes Cash, Ferdinand Luger, Adam Kinnaird, Brian Wodlinger, Parvin Mousavi, Purang Abolmaesumi

cs.CV cs.AIcs.LG ·submitted 2026-11-06 06:33 UTC · v1

Abstract

Purpose: Micro-ultrasound ($μ$US) is a promising modality for prostate cancer (PCa) detection, but identifying suspicious tissue depends heavily on clinical experience. Models trained on sparse, noisy core-level pathology offer little insight into their decisions and can fail under domain shift. Clinical use needs a traceable decision process and a flag for uncertain predictions. Methods: We introduce ProtoCouncil, in which three foundation encoders (MedSAM, DINOv3 and V-JEPA 2.1) learn case-based prototypes at three anatomical levels: whole gland, needle track and gland sectors. Prototypes are projected onto real training-core regions, and label-free fusion keeps every class logit as a bias plus an exact sum of prototype similarity contributions. Encoder disagreement triggers selective prediction. Results: In five-fold patient-level cross-validation (6,588 cores, 693 patients), ProtoCouncil reaches 82.9% AUROC for clinically significant PCa (csPCa, Grade Group $\geq$3), 4.3 points above the best previously published method. In zero-shot evaluation on two external cohorts, ProtoCouncil achieves higher all-cancer and csPCa AUROC than all previous methods. Nearest same-class exemplars match test-core tumor involvement better than random same-class cases. Externally, csPCa accuracy falls from 79% when encoders agree to 27% when two oppose the fused call. Abstaining on disagreement raises balanced accuracy by 7 and 15 points, while retaining 58% and 54% of the cores. Conclusion: ProtoCouncil grounds core-level predictions in exact similarity-based evidence from real, anatomically indexed training cases, which makes its reasoning interpretable. It achieves the highest csPCa AUROC across three cohorts and identifies unreliable predictions through encoder disagreement.

Comment
12 pages, 3 figures, Under Review

Closest papers

Nearest neighbours by meaning across the whole index.

Weakly Supervised Spatial Grounding for Discriminative Attention-Based Ultrasound-Histopathology Alignment in Prostate Cancer Grading

cs.CV ·2026-09-14 ·Obed Korshie Dzikunu, Emma Willis, Mohammad Mahdi Abootorabi, Mohamed Harmanani, Zhuoxin Guo +5 more
similarity 0.71
Abstract

Unpaired cross-modal distillation transfers grade structure from histopathology into a micro-ultrasound (micro-US) encoder by aligning a pooled needle-region embedding to a frozen histopathology teacher under grade-group correspondence alone. A single objective is thereby required to serve two distinct functions: rendering patch features discriminative of tissue state, and selecting which patches enter the pooled representation. We decouple them. Weak spatial supervision derived from percentage involvement, recorded routinely at biopsy, constrains the predicted proportion of malignant tissue within each core, acting on the encoder features independently of the alignment objective. The alignment loss then operates on features that differ across a core, and attention concentrates on a subset of patches rather than remaining near-uniform. On 7,166 biopsy cores from 811 patients across seven centers under patient-level 5-fold cross-validation, the method reaches 67.1 macro AUC and 68.5 csPCa AUC, against 61.2 and 52.8 for the existing unpaired alignment method and 63.1 and 62.6 for the strongest unimodal baselines. Ablation against existing attention regularizers designed to prevent attention-uniformity collapse shows that such regularizers do not substitute for label-derived supervision: they constrain the attention distribution, whereas the signal required acts on the features that attention reads.

0.17

Learning Prostate Anatomy at Test Time for Cancer Detection in Micro-Ultrasound

cs.CV cs.LG ·2026-08-20 ·Obed Korshie Dzikunu, Mohammad Mahdi Abootorabi, Mohamed Harmanani, Paul F. R. Wilson, Emma Willis +5 more
code/data similarity 0.71
Abstract

Domain shift across clinical centers using different imaging hardware or acquisition protocols remains a fundamental barrier to deploying deep learning models for prostate cancer (PCa) detection. Existing test-time adaptation (TTA) methods address distribution shift through entropy minimization or augmentation-based self-supervision, correcting for statistical differences in image appearance but ignoring the anatomical structure of the target domain. We propose ANT, a segmentation-guided TTA framework that adapts a pretrained cancer detection encoder to the target domain by solving an auxiliary prostate segmentation task at test time, supervised by pseudo-masks from a frozen pretrained segmentation network. By aligning encoder representations to prostate anatomy in the target domain, ANT corrects domain-specific feature drift while preserving cancer-discriminative structure. The model was trained on 693 patients imaged with an earlier-generation micro-ultrasound scanner in a multi-center clinical trial, and evaluated on 118 patients acquired with a newer-generation system across two centers in another clinical trial. Under a leave-one-center-out protocol with identical evaluation conditions across all methods, ANT improves mean AUC by 2.9% and 3.6% at the biopsy-core and patient levels, respectively, over no adaptation, outperforming TTA baselines. Code is available at: https://github.com/ObedDzik/ant.git.

0.52

Transferable Named Sparse Features for Morphology-based Gleason Grading

eess.IV cs.CV ·2026-11-18 ·Argyrios Zafeiriou, Athanasios Kallipolitis, Ilias Maglogiannis
similarity 0.66
Abstract

Deep learning systems grade prostate biopsies at the level of pathologists, but most report a grade without the glandular architecture that justifies it. This work presents a grading system built on a sparse code over the tokens of a pathology foundation model. A sparse autoencoder pretrained on biopsies is aligned with multi-reader annotations, so that 69 of its 2048 features are named after Gleason morphologies such as cribriform glands, cords, and comedonecrosis. The same code feeds a grading network, which reads all features to predict Gleason patterns and the Grade Group, while morphology maps read directly from the named features. We evaluate the system on five public datasets that include needle biopsies, tissue-microarray cores, multi-reader annotations, and three scanners. The morphology maps remain stable across alignment runs and, without retraining, detect cribriform glands in external biopsies (area under the receiver operating characteristic curve, AUROC, 0.849) and pattern 5 in unseen cores when evaluated by up to six pathologists (AUROC 0.846 to 0.919). In an independent biopsy cohort, Grade Group agreement with three pathologists on Leica scans is close to their agreement with each other. Removing the named features reduces the corresponding Gleason pattern predictions by 49% to 98%, with effects larger than those from 20 activity-matched random feature removals. These results show that a shared sparse representation can support competitive Gleason grading while providing named morphological evidence that transfers across datasets and whose contribution to grading can be measured directly.

0.23

Zero-Shot Adaptation of Medical Vision Foundation Models for High-Frequency Micro-Ultrasound Prostate Segmentation

cs.CV cs.LG ·2026-08-14 ·Ayusha Abbas, Saram Abbas, Kabita Adhikari
similarity 0.66
Abstract

Prostate cancer claims a life every 80 seconds. Early detection is needed to prevent disease progression, and both PSA density calculation and biopsy decisions rely on knowing the exact boundary of the gland. Conventional ultrasound at 6-12 MHz blurs this boundary, missing one in three high-risk cancers. Micro-ultrasound (29 MHz) improves resolution threefold but introduces dense acoustic speckle that obscures the outer wall; given the same image, two clinicians draw outlines differing by over 10% in area. Supervised methods are costly and generalise poorly across scanners. Can a foundation model segment the prostate with no training data? We present the first zero-shot pipeline for this modality: MedSAM, pre-trained on over 1.5 million medical images, localises the prostate; we then apply CLAHE to sharpen the outer wall, binary dilation to recover missed pixels, and Fourier smoothing (4 modes, s=1.05) to refine the boundary. MedSAM requires a spatial prompt, so we evaluate bounding-box and point-click strategies across 75 patients of the Micro-Ultrasound Prostate Segmentation dataset (2,621 slices). On the 20-patient held-out test set, the pipeline reduces mean boundary-distance error by 45% (Dice 0.749+/-0.043 to 0.865+/-0.029; HD95 217.2+/-36.9 to 120.1+/-26.1 px), reaching Dice 0.859 across the cohort. Its mean overlap shows no significant difference from the three non-expert rater groups (p>0.19), while segmenting 38-52% more consistently (lower inter-patient standard deviation). Point-click prompts fail regardless of placement (best Dice=0.350), because speckle gives no stable local contrast. Only an approximate bounding box is required, so any clinic can deploy it without data collection, annotation, or retraining.

0.04

When Two Tracers Disagree: An Investigation of Multimodal Fusion for Clinical PET/CT Segmentation

cs.CV ·2026-08-19 ·Jack A. Johnson, Bartłomiej W. Papież
publishedcode/data similarity 0.66
Abstract · 10 pages (8 pages main content and 2 pages of references), 2 figures, 2 tables, accepted to MICCAI 2026 Cancer Prevention, Detection, and In…

PSMA and FDG PET/CT visualise complementary biological information in prostate cancer. Combining both tracers could capture heterogeneous tumour phenotypes that may be missed by either alone, yet there is no consensus on effective deep learning architectures for fusing these modalities. We evaluated multimodal image-fusion strategies for automatic whole-body PET/CT lesion segmentation to estimate total tumour burden. Using the public DEEP-PSMA Challenge dataset, we trained tracer-specific 3D nnU-Net baselines and compared (i) early fusion with a single encoder and one decoder (OEOD) or two decoders (OETD), and (ii) intermediate fusion via a dual-encoder cross-attention U-Net (DECA-UNet). Tracer-specific baselines performed strongly (PSMA Dice = 0.93; FDG = 0.81). Fusion yielded mixed results: OEOD produced a combined Dice of 0.90 (on an easier, non-tracer-specific task), whilst the tracer-specific fusion models reached PSMA/FDG = 0.69/0.64 (OETD) and 0.76/0.57 (DECA-UNet). Whilst fusion often provided reasonable PSMA segmentation, FDG performance degraded and no strategy consistently exceeded the single-tracer baselines. Under the evaluated setting, tracer-specific models remain the stronger baseline; clinically useful gains from multimodal fusion will likely require architectures that better preserve tracer specific representations. Our code is available at: https://github.com/JackJ3636/DEEP_PSMA_code

0.45

ST-Dist: Distilling Spatial Transcriptomics Predictions into Interpretable Gene Axes for Distant Metastasis Prediction

eess.IV ·2026-11-11 ·Sandesh Pokhrel, Hamid Manoochehri, Beatrice S. Knudsen, Tolga Tasdizen
similarity 0.65
Abstract

Distant metastasis at diagnosis determines the treatment of prostate cancer, but predicting it from routine biopsy slides is challenging as the signs of metastasis are not clearly localized and are more subtle than in standard tumor detection and subtyping tasks. Multiple instance learning (MIL) on pathology foundation-model features has become the standard approach when labeled data are abundant, but such models remain hard to interpret. Distant metastasis is further challenging, because confirming the label requires clinical follow-up beyond the routine H&E slides. To this end, we propose ST-Dist, which distills the gene expression predicted by a spatial transcriptomics (ST) model into a linear head mapping each tile's foundation-model features onto named gene axes. The slide's projections along these interpretable gene axes are then used for distant metastasis prediction with a simple logistic regression. On 497 prostate needle biopsies (205 patients), ST-Dist reaches an AUROC of 91.37%, above nine MIL baselines. It remains competitive on the public TCGA-COAD and TCGA-KIRC cohorts, and it has the highest mean AUROC over the three cohorts. The ablations on the prostate biopsies show that the gene axes outperform a linear probe on encoder features, dimension-matched principal components, random gene panels and the ST model's own predicted expression, and the gain over the probe holds on all 13 pathology encoder settings that we tested. ST-Dist thus offers a simple, accurate and interpretable route from H&E to distant metastasis prediction.

0.12

Conditional Diffusion-Based Generation of T2-Weighted Prostate MRI for Clinically Significant Prostate Cancer Classification

cs.CV ·2026-11-01 ·Xavier Rafael-Palou, Alejandro Vergara-Richart, Ignacio Iborra Roncales, Carmen Prieto-de-la-Lastra, Andreu Antolin-Redondo +2 more
similarity 0.65
Abstract

Scarce and unrepresentative training data limit the performance of prostate MRI prediction models. Synthetic T2-weighted (T2W) MRI may augment training data containing clinically significant prostate cancer (csPCa) and transition zone (TZ) lesions. In this retrospective, single-center, ethics-committee-approved study, we developed a conditional generative model for T2W prostate MRI extending MAISI-v2 with csPCa class, zonal, and lesion-mask-guided conditioning, incorporating a relative advantage weighted loss fine-tuned on 1,303 patients (1,654 lesions). Fidelity was assessed by incremental ablation, and downstream utility was evaluated with T2W-based csPCa classifiers across five simulated training-data scenarios, each testing 18 synthetic-data configurations. The proposed model reduced Fréchet inception distance (FID) from 13.28 (pretrained MAISI-v2) to $2.04 \pm 0.06$ internally (PI-CAI: $3.83 \pm 0.51$). Synthetic augmentation significantly increased AUC in all five scenarios (+0.027 to +0.088; adjusted $p = 0.016$--$0.043$), though cross-institutional augmentation of PI-CAI yielded a non-significant gain (+0.013; $p = 0.397$). Overall, our model improved T2W MRI fidelity, and synthetic images improved csPCa classification under simulated data constraints, although benefit did not transfer significantly across institutions.

0.21

HERO: Histology Encoder for Robust Representation in Oncology

cs.CV ·2026-09-28 ·Zhi Li, Eghbal Amidi, Yating Cheng, Tyson Dawson, Gorkem Can Ates +9 more
benchmarkcode/data similarity 0.65
Abstract · 22 pages, 4 figures, 13 tables; author information updated; scientific content unchanged

Foundation models trained on large pathology image corpora now provide strong, transferable representations for computational pathology. Over the past few years a series of such models has been released, each trained on more slides than the last; on standard classification and segmentation benchmarks, the leading models are now separated by small margins. In clinical use, however, the foundation model is applied to images from hospitals, scanners, and staining protocols outside its training data. Encoders generally embed these acquisition factors alongside biological information, which may introduce downstream errors and hinder safe clinical adoption. A pathology foundation model should therefore be robust to acquisition shift without giving up representation quality, yet robustness is seldom the axis along which models are compared. In this report, we introduce HERO (Histology Encoder for Robust Representation in Oncology), a ViT-G/14 pathology foundation model trained with the DINO and iBOT objectives and refined with high-resolution Gram anchoring on a morphology-balanced corpus of 500 million tiles from approximately 575,000 clinical whole-slide images. Across the evaluated public benchmarks, HERO shows the strongest robustness to center, scanner, and stain variation among the compared state-of-the-art foundation models, performs comparably on tile-level classification, segmentation, and gene-expression prediction, ranks first on average across 39 evaluated slide-level clinical tasks, and, under an equal-weighted framework-level analysis, has the best average rank across the six benchmark frameworks.

0.22